Most people reach their target dose around week 1317
The pharmacist submits the request to the bridge program, which reviews it
Resmetirom followed with a significant increase in risk, presenting an RR of 1.77 (95% CI: 1.08 to 2.88, p = 0.0223)
Valerie Van Buren, Director of Quality Improvement and Performance, and Terry McKeever, Director of Quality Management, will be the lead presenters
Found Health's telehealth weight loss platform has seen increased consumer interest from consumers researching GLP-1 medication access, insurance coverage pathways, and program pricing in 2026
A comprehensive search of the literature on preclinical studies and human data published in English was performed from Jan 2013 to Dec 2024 to identify the various effects of GLP-1Ra on bone health